MedPath

CLOSM Trial: Groin Closure Using Layered Option for Suture Material

Not Applicable
Recruiting
Conditions
Vascular Diseases
Registration Number
NCT06990425
Lead Sponsor
The Cleveland Clinic
Brief Summary

This is a randomized controlled trial comparing groin closure after vascular intervention with Vicryl suture versus PDS (polydioxanone) suture. This will be a single center trail performed at CCF main campus. Patients will be enrolled in a prospective fashion and will be randomized 1:1 to either PDS or Vicryl closure. Patients undergoing bilateral groin exposure will be randomized to receive both closure types to either groin.

Detailed Description

Previous research has provided insights into the properties of various suture materials, yet there remains a gap in our understanding of their relative effectiveness in groin closure specifically within the context of vascular surgery. The lack of definitive evidence on whether Vicryl or PDS (polydioxanone) sutures offer superior outcomes necessitates further investigation. This study aims to address this gap by conducting a head-to-head comparison of these sutures, focusing on their impact on postoperative groin complications.

This is a randomized controlled trial comparing groin closure after vascular intervention with Vicryl versus PDS. This will be a single center trail performed at CCF main campus. Patients will be enrolled in a prospective fashion and will be randomized 1:1 to either PDS or Vicryl closure. Patients undergoing bilateral groin exposure will be randomized to receive both closure types to either groin.

The primary objective of this randomized controlled trial (RCT) is to evaluate the effectiveness of Vicryl versus PDS sutures in reducing groin complications following vascular surgery.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
259
Inclusion Criteria
  • All patients > 18 years who undergo ELECTIVE vascular surgery that would require groin incisions
  • Patients with to undergo ELECTIVE bilateral groin incisions will be matched to receive closure with PDS in one groin and Vicryl in the other groin
Exclusion Criteria
  1. Age 17 or younger
  2. Prisoners
  3. Pregnant patients
  4. Emergent cases
  5. Active groin infection prior to intervention
  6. History of prior surgical groin access (re-operative groin)
  7. Groin closure after extracorporeal membrane oxygenation (ECMO)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate of groin complication30 days and 1 year

Number of occurrence of the access site complication

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Cleveland Clinic
🇺🇸Cleveland, Ohio, United States
Ahmed Sorour, MD
Sub Investigator
Francis Caputo, MD
Principal Investigator
Jon Quatromoni, MD
Sub Investigator
Ali Khalifeh, MD
Sub Investigator
Ravi Ambani, MD
Sub Investigator
Courtney Hanak, MD
Sub Investigator
Nicohlas Hoell, MD
Sub Investigator
Reinis Ozolins, MD
Sub Investigator
Connor Crudeli, MD
Sub Investigator
Thomas Perry, MD
Sub Investigator
Emma Fulton, MD
Sub Investigator
Nathan Reinert, MD
Sub Investigator
John Taaffe, MD
Sub Investigator
Keith Garber, MD
Sub Investigator
Bryan Cass, MD
Sub Investigator
Brendan Jones, MD
Sub Investigator
Michael Gibbons, MD
Sub Investigator
Blake Westling, MD
Sub Investigator
Abdullah Khan, MD
Sub Investigator
Ryan Ellis, MD
Sub Investigator
Lee Kirksey, MD
Sub Investigator
Sami Abou-Assi, MD
Sub Investigator
Antoine Marc, MD
Sub Investigator
D'Andre Williams, MD
Sub Investigator
Alice Alexander, MD
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath